arginine has been researched along with amphotericin b in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Foresta, P; Martelli, EA; Riccardi, C | 1 |
| Cornaglia-Ferraris, P; Perezzani, L; Rossi, E; Stradi, R | 1 |
| Epstein, FH; Rosen, S; Silva, P; Spokes, K | 1 |
| Farah, A; Pessah, N; Yamodis, ND | 1 |
| Beshara, G; Ghali, R; Sabra, R; Serhal, H; Sharaf, LH; Zeinoun, N | 1 |
| Aires do Nascimento, FBS; Cavalcanti, BC; de Andrade Neto, JB; Nobre Junior, HV; Odorico de Moraes, M; Pérez, L; Pinazo, A; Ramos da Silva, A; Rocha da Silva, C; Serpa Sampaio Moreno, L | 1 |
| Dennery, J; Hopkins, HS; Hugenholtz, H; Montpetit, V; Nundy, D; Prior, J; Richard, MT; Stewart, DJ | 1 |
| Selleslag, D | 1 |
1 review(s) available for arginine and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for arginine and amphotericin b
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Immunorestorative properties of ST 789 on experimentally immunosuppressed and infected mice.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Arginine; Bacterial Infections; Cyclophosphamide; Female; Hypoxanthines; Immune Tolerance; Male; Mice; Mice, Inbred BALB C; Mycoses | 1992 |
Retention of amphotericin-B therapeutic efficacy at half doses by synergistic activation of phagocytes.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Arginine; Candidiasis; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Female; Hypoxanthines; Immunocompromised Host; Immunologic Deficiency Syndromes; Mice; Mice, Inbred BALB C; Neutrophils; Phagocytosis | 1991 |
Effect of glycine on medullary thick ascending limb injury in perfused kidneys.
Topics: Amino Acids; Amphotericin B; Animals; Arginine; Glycine; Hypoxia; In Vitro Techniques; Indomethacin; Kidney Medulla; Kidney Tubules, Distal; Male; omega-N-Methylarginine; Oxygen Consumption; Perfusion; Rats; Rats, Inbred Strains | 1991 |
The relation of changes in sodium transport to protein-bound disulfide and sulfhydryl groups in the toad bladder epithelium.
Topics: Aldosterone; Aminophylline; Amphotericin B; Animals; Anura; Arginine; Biological Transport, Active; Cell Membrane Permeability; Cortisone; Cyclic AMP; Dactinomycin; Electrophysiology; Epithelium; In Vitro Techniques; Lysine; Osmolar Concentration; Oxytocin; Photometry; Protein Binding; Sodium; Sulfhydryl Compounds; Sulfides; Urinary Bladder; Vasopressins | 1969 |
Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
Topics: Amphotericin B; Angiotensin II; Animals; Antifungal Agents; Arginine; Candida albicans; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Endothelins; Glomerular Filtration Rate; Imidazoles; In Vitro Techniques; Injections, Intravenous; Kidney Diseases; Liposomes; Male; Nitric Oxide; Nitroso Compounds; Oligopeptides; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 2001 |
Arginine-phenylalanine and arginine-tryptophan-based surfactants as new biocompatible antifungal agents and their synergistic effect with Amphotericin B against fluconazole-resistant Candida strains.
Topics: Amphotericin B; Antifungal Agents; Arginine; Biofilms; Candida; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Phenylalanine; Surface-Active Agents; Tryptophan | 2021 |
[Isolation of drug-resistant mutant cells].
Topics: Alkylating Agents; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aphidicolin; Camptothecin; Cell Separation; Drug Resistance; Etoposide; Humans; Hydroxamic Acids; Lovastatin; Monensin; Nucleic Acids; Teniposide; Toxins, Biological; Tunicamycin | 1991 |
Penetration of teniposide (VM-26) into human intracerebral tumors. Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin B or oral glycerol.
Topics: Amphotericin B; Astrocytoma; Brain Neoplasms; Glycerol; Humans; Kinetics; Meningioma; Podophyllotoxin; Teniposide | 1984 |
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole | 2006 |